Swedish Orphan Biovitrum, also known as Sobi, has entered into a definitive agreement to acquire San Diego, USA-based biotech ...

Swedish rare disease specialist Hansa Biopharma announced a reorganization of its European and International Commercial and ...

Japan’s Tanabe Pharma, formerly known as Mitsubishi Tanabe and now owned by Bain Capital, has obtained approval from the ...

On December 12, 2025, the US Food and Drug Administration approved Johnson & Johnson subsidiary Janssen Biotech’s Akeega (niraparib and abiraterone acetate with prednisone for adults with deleterious ...

M&A news last week featured Mirum Pharmaceuticals announcing plans to acquire fellow USA-based Bluejay Therapeutics and its ...

The US Food and Drug Administration (FDA) on Friday announced it has approved two new oral medicines to treat a common ...

US late-stage rare disease focused pharma Rezolute announced disappointing top-line results from its Phase III sunRIZE study ...

Medra, a US company developing the first platform for physical AI scientists, has announced a $52 million Series A financing.

Danish biotech Sidera Bio has raised about 700 million Kroner ($109 million) in a series A financing, one of the largest ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its ...

British pharma major AstraZeneca (LSE: AZN) has joined a near-$100 million series A and A+ financing round for Syneron Bio, a ...

Eli Lilly has shown the strength of its obesity pipeline beyond its on-market blockbuster Mounjaro (tirzepatide) ...